Please ensure Javascript is enabled for purposes of website accessibility

The Key Earnings Details of the Medical Device Industry

By Dan Carroll and Max Macaluso - Apr 24, 2013 at 10:43AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

What's happened in this industry so far through earnings season -- and how will results fare for one leading company set to report this week?

We're into the heart of earnings season, and several of the medical device industry's biggest players have already reported quarterly results. Johnson & Johnson (JNJ 0.30%) led off among the biggest players, with fellow diversified health care firm Abbott Labs (ABT 4.13%) and more concentrated company St. Jude Medical (STJ) following suit last week.

In that time, a few key trends have stood out that investors should take note of – particularly before Boston Scientific's (BSX 2.64%) earnings emerge this Thursday. Fool contributor Dan Carroll and health care analyst Max Macaluso discuss how the above companies fared this earnings season, and if the trends we've seen will come to shape Boston Scientific's earnings as well later this week.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Johnson & Johnson Stock Quote
Johnson & Johnson
JNJ
$178.62 (0.30%) $0.54
Abbott Laboratories Stock Quote
Abbott Laboratories
ABT
$114.24 (4.13%) $4.53
Boston Scientific Corporation Stock Quote
Boston Scientific Corporation
BSX
$40.87 (2.64%) $1.05
St. Jude Medical, Inc. Stock Quote
St. Jude Medical, Inc.
STJ

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
338%
 
S&P 500 Returns
119%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/17/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.